Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > SERNOVA paid a ridiculous amount for the PP
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by stockhunter1on Mar 09, 2021 11:26am
203 Views
Post# 32752551

RE:RE:SERNOVA paid a ridiculous amount for the PP

RE:RE:SERNOVA paid a ridiculous amount for the PPI for one am VERY happy money was raised  at 1.20...opposed to continued dilution in the 20 CENT range, just to keep the boat floating... think about that!!! Now we are flush with cash from warrants and the bought deal and are in a strong position from which to do negotiations...how much has this de-risked us?? and how much value has been added to our market cap from this bought deal? Perhaps it would be better to be range bound @.25 cents and on our knees when trying to negotiate... I THINK NOT.  I for one am very happy at this NEW level while we await news on multiple fronts. I am holding for fair Value...one catalyst may be all it takes. All my shares are in Diamond hands...are yours?      
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities